BTMD - SHBAN Orders Up 3,330% on SHBAN Go Anywhere Hand Sanitizer Market Wire "US Press Releases "
DALLAS, TX -- (MARKET WIRE) -- 01/26/07 -- BioTech Medics, Inc. (PINKSHEETS: BTMD) announced today that their Dallas FDA-compliant manufacturing plant will be processing a second batch of BioTech's SHBAN(TM) GO Anywhere Hand Sanitizer Mist - 3 oz. bottles next week.
"We are excited to be able to place a second order in less than six weeks from our first order. We are getting unsolicited calls from those who have bought the product telling us how wonderful the SHBAN Hand Sanitizer is to use," said Keith Houser, CEO.
SHBAN has been clinically proven to kill the Avian Bird Flu and other viruses upon contact without harming humans, animals and the environment. The clear superiority of SHBAN over other sanitizers is that SHBAN is longer-lasting as it leaves an invisible protective coating on your hands until you rub or wash it off. SHBAN does not evaporate within one minute after application (compared to alcohol-based hand sanitizers). SHBAN is non-toxic (when used as directed), it is non-bleaching and has no toxic odors.
SHBAN is currently being voluntarily used by flight attendants who work for a major airline based out of Dallas, Texas . BioTech Medics developed SHBAN 3 oz. Go Anywhere Hand Sanitizer so that it may pass the TSA carry-on guidelines for airline passengers and be used during travel.
The SHBAN(TM) solution, in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. SHBAN has previously been tested by Baylor Medical Center in Houston , Louisiana State University , UT Houston. SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391.
BioTech Medics is a 21st Century Alternative Medicine company. BioTech has Pain Management & Wellness Centers which feature the NeuroLase Therapeutic Medical Laser, FDA cleared to reduce or eliminate muscular, skeletal or arthritic pain without drugs or surgery.
Safe Harbor for Forward-Looking Statements
This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.
Contact:
BTMD Investor Relations
1-800-200-2458
AI
